Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Huma…

New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in ...
WebMD

FDA Approves Combined Use of Zepzelca and Atezolizumab as First-Line Maintenance Treatment for Advanced Small-Cell Lung Cancer

Zepzelca (lurbinectedin) is a chemotherapy medicine that damages the DNA of cancer cells by disrupting their protein function and ability to repair DNA. This action makes it difficult for cancer cells ...